Day 1

TCT 2014 – Poster Presentation | Inspiron Registry: Safety and efficacy in a group of patients at very high risk.

solaci
solaci
499
0

6_poster_presentation

TCT
2014-09-14

Previous article
TCT 2014.
Next article
Mitra-Clip: a valid alternative for high risk patients
solaci
solaci

More articles by this author

ISAR-CLOSURE: FemoSeal and ExoSeal versus manual compression after femoral access

solaci - 0
Previous studies with vascular closure devices showed shorter hemostasis and less downtime post-procedure. This study compared the safety and efficacy of two vascular closure...

CLEAN-TAVI: transcatheter aortic valve replacement with cerebral protection

solaci - 0
The stroke is a leading complication of post transcatheter aortic valve implantation increasing up to 3 times the mortality of these patients. In the...

PARTNER cohort B: 5-year results of a balloon-expandable valve on inoperable patients

solaci - 0
This study included 358 patients considered inoperable, randomized to TAVR with expandable balloon valve versus conservative treatment. The 5-year end points included all-cause mortality,...

CoreValve US Pivotal Trial: 2-year results of the self-expanding valve on inoperable patients

solaci - 0
This study evaluated the safety and effectiveness of the CoreValve transcatheter valve replacement in patients with severe aortic stenosis with extreme risk for surgery.  The...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

Day 1

ISAR-CLOSURE: FemoSeal and ExoSeal versus manual compression after femoral access

Previous studies with vascular closure devices showed shorter hemostasis and less downtime post-procedure. This study compared the safety and efficacy...
solaci -
SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

Prehospital heparin in STEMI: A safe strategy associated with improved early reperfusion

Dr. Omar Tupayachi - 0
Early reperfusion remains the main prognostic determinant in patients with ST-segment elevation myocardial infarction (STEMI). Although primary percutaneous coronary intervention (PCI) is the treatment...

SAPIEN 3 TAVI Durability: Ten-Year Follow-Up in Intermediate-Risk Patients

Dr. Omar Tupayachi - 0
The durability of transcatheter bioprosthetic valves used in TAVI remains one of the key unanswered questions as indications continue to expand toward patients with...

Aneurysm Sac Regression Predicts Better Clinical Outcomes After EVAR?

Dr. Juan Manuel Pérez - 0
Aneurysm sac regression following endovascular abdominal aortic aneurysm repair (EVAR) has been proposed as a marker of favorable remodeling and effective aneurysm exclusion. However,...